發(fā)布時間：2018-03-20 11:14

  本文選題：缺血性中風(fēng)恢復(fù)期　切入點：溫陽復(fù)元方　出處：《廣西中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:探討溫陽復(fù)元方治療缺血性中風(fēng)病的理論依據(jù),以及觀察溫陽復(fù)元方治療缺血性中風(fēng)恢復(fù)期的有效性及安全性,以期為中風(fēng)病的治療開拓新的思路,并為本方更好地應(yīng)用于臨床打下堅實基礎(chǔ)。方法:根據(jù)國內(nèi)對缺血性中風(fēng)的診斷標(biāo)準(zhǔn),將符合納入標(biāo)準(zhǔn)的80例患者隨機分為治療組與對照組,每組40例。兩組在常規(guī)治療基礎(chǔ)上分別給予溫陽復(fù)元方和補陽還五湯治療,治療28天為一個療程。觀察兩組患者治療前后的神經(jīng)功能缺損評分、運動功能評分、生活能力評分、中醫(yī)證候評分的變化情況。結(jié)果:(1)臨床療效:治療組37例,基本痊愈7例,顯效17例,有效10例,無效3例,總有效率為91.89%;對照組36例,基本痊愈4例,顯效12例,有效10例,無效10例,總有效率為72.22%。兩組比較差異有統(tǒng)計學(xué)意義(P0.05),說明治療組明顯優(yōu)于對照組。(2)NIHSS評分:溫陽復(fù)元方與補陽還五湯均能改善缺血性中風(fēng)恢復(fù)期患者的NIHSS積分(P0.05或P0.01),治療前后差值比較(P0.05),治療組優(yōu)于對照組,提示溫陽復(fù)元方可明顯改善患者神經(jīng)缺損功能,其療效優(yōu)于補陽還五湯組。(3)肢體運動功能評分(Fugl-Meyer):溫陽復(fù)元方與補陽還五湯均能改善缺血性中風(fēng)恢復(fù)期患者的Fugl-Meyer評分(P0.05或P0.01),治療后比較,治療組優(yōu)于對照組(P0.05),提示溫陽復(fù)元方可明顯改善患者運動功能評分,其療效優(yōu)于補陽還五湯組。(4)日常生活能力評分(ADL):溫陽復(fù)元方與補陽還五湯均能改善缺血性中風(fēng)患者的ADL評分(P0.05或P0.01),治療后比較,治療組優(yōu)于對照組(P0.05),提示溫陽復(fù)元方可明顯改善患者生活能力其療效優(yōu)于補陽還五湯組。(5)中醫(yī)證候評分:溫陽復(fù)元方與補陽還五湯均能改善缺血性中風(fēng)患者的中醫(yī)癥候積分(P0.05或P0.01),治療后比較,治療組優(yōu)于對照組(P0.05),提示溫陽復(fù)元方可明顯改善患者中醫(yī)癥候評分,其療效優(yōu)于補陽還五湯組。結(jié)論:本研究顯示,溫陽復(fù)元方治療缺血性中風(fēng)恢復(fù)期患者療效確切、安全,能夠改善缺血性中風(fēng)恢復(fù)期患者的NIHSS、Fugl-Meyer、ADL、中醫(yī)癥候評分。
[Abstract]:Objective: to explore the theoretical basis of Wenyang Fuyuan recipe in the treatment of ischemic stroke, and to observe the efficacy and safety of Wenyang Fuyuan prescription in the treatment of ischemic stroke in convalescence, so as to open up new ideas for the treatment of apoplexy. Methods: according to the diagnostic criteria of ischemic stroke in China, 80 patients with ischemic stroke were randomly divided into treatment group and control group. 40 cases in each group were treated with Wenyang Fuyuan recipe and Buyang Huanwu decoction on the basis of routine treatment for 28 days. The neurological impairment score, motor function score and life ability score were observed before and after treatment. Results: in the treatment group, 37 cases were basically cured, 17 cases were markedly effective, 10 cases were effective, 3 cases were ineffective, the total effective rate was 91.89%, while 36 cases in the control group, 4 cases were basically cured, 12 cases were effective, 10 cases were effective. Ineffective 10 cases, The total effective rate was 72.22.The difference between the two groups was statistically significant (P 0.05), which indicated that the treatment group was obviously superior to the control group in the score of NIHSS: both Wenyang Fuyuan recipe and Buyang Huanwu decoction could improve the NIHSS score of patients with ischemic stroke in convalescent stage (P0.05 or P0.01), before treatment. The latter difference was compared with that of the control group, and the treatment group was superior to the control group. It is suggested that Wenyang Fuyuan decoction can obviously improve the function of nerve defect in patients. The curative effect was better than that of Buyang Huanwu decoction group. 3) limb motor function score: both Wenyang Fuyuan decoction and Buyang Huanwu decoction could improve the Fugl-Meyer score of patients with ischemic stroke in convalescence stage (P0.05 or P0.01). The treatment group was superior to the control group (P 0.05), suggesting that Wenyang Fuyuan Fang could improve the motor function score of the patients. The curative effect was better than that of Buyang Huanwu decoction group. 4) the ability of daily living (ADL): both Wenyang Fuyuan decoction and Buyang Huanwu decoction could improve the ADL score of ischemic stroke patients (P0.05 or P0.01). The treatment group is superior to the control group (P 0.05), indicating that Wenyang Fuyuan decoction can obviously improve the patients' living ability and its curative effect is better than Buyang Huanwu decoction group. 5) TCM syndromes score: both Wenyang Fuyuan recipe and Buyang Huanwu decoction can improve the middle of ischemic apoplexy patients. The score of medical symptoms was P0.05 or P0.01A, compared with that after treatment, The treatment group is superior to the control group (P 0.05), suggesting that Wenyang Fuyuan decoction can obviously improve the TCM symptom score of the patients, and its curative effect is better than that of Buyang Huanwu decoction group. Conclusion: this study shows that the therapeutic effect of Wenyang Fuyuan decoction on patients with ischemic stroke in recovery stage is definite and safe. It can improve NIHSS Fugl-Meyer ADL, TCM symptom score.
【學(xué)位授予單位】：廣西中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R743.3

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊碩;邢袁若愚;張興榮;;小續(xù)命湯治療中風(fēng)恢復(fù)期94例臨床觀察[J];中藥藥理與臨床;2016年04期

2 張國慶;王德亮;林媛媛;郭閆平;曾現(xiàn)偉;;通竅活血湯化裁方對出血性中風(fēng)恢復(fù)期瘀血阻絡(luò)證患者神經(jīng)功能的影響[J];解放軍預(yù)防醫(yī)學(xué)雜志;2016年S1期

3 孫良明;程發(fā)峰;王雪茜;王慶國;;清開靈注射液治療急性中風(fēng)的系統(tǒng)評價和Meta分析[J];中國中醫(yī)急癥;2016年05期

4 黃金龍;;鎮(zhèn)肝熄風(fēng)湯加減治療中風(fēng)36例臨床觀察[J];中國民族民間醫(yī)藥;2016年02期

5 楊鵬飛;楚世峰;陳乃宏;;黨參的藥理學(xué)研究進(jìn)展及其抗腦缺血再灌注損傷的機制[J];湖南中醫(yī)藥大學(xué)學(xué)報;2015年12期

6 孫政華;邵晶;郭玫;;黨參化學(xué)成分及藥理作用研究進(jìn)展[J];安徽農(nóng)業(yè)科學(xué);2015年33期

7 陳海峰;胡躍強;甘業(yè)賢;毛丹鳳;;溫陽法治療中風(fēng)概述[J];新中醫(yī);2015年11期

8 朱瑞麗;易浪;董燕;王培訓(xùn);;附子中3種烏頭原堿對巨噬細(xì)胞的抗炎作用[J];廣州中醫(yī)藥大學(xué)學(xué)報;2015年05期

9 唐農(nóng);胡躍強;吳林;;從“陽虛為本”論中風(fēng)病的次第治療[J];中醫(yī)雜志;2015年12期

10 王瑩;y囇，

本文編號：1638834